These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21147279)

  • 1. Care for patients with ultra-rare disorders.
    Hennekam RC
    Eur J Med Genet; 2011; 54(3):220-4. PubMed ID: 21147279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rare diseases in pulmonary medicine and its challenges].
    Wencker M; Teschler H; Vogelmeier C; Koczulla R
    Pneumologie; 2012 Jul; 66(7):437-41. PubMed ID: 22692970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimising treatment for people with rare diseases].
    Lund AM; Skovby F
    Ugeskr Laeger; 2006 Apr; 168(15):1547-50. PubMed ID: 16640978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Prader-Willi Syndrome Clinical Research Database: an aid in the investigation of a rare genetically determined neurodevelopmental disorder.
    Holland A; Whittington J; Cohen O; Curfs L; Delahaye F; Dudley O; Horsthemke B; Lindgren AC; Nourissier C; Sharma N; Vogels A
    J Intellect Disabil Res; 2009 Jun; 53(6):538-47. PubMed ID: 19457156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Needs in rare diseases during paediatric age].
    Gaite L; García Fuentes M; González Lamuño D; Alvarez J
    An Sist Sanit Navar; 2008; 31 Suppl 2():165-75. PubMed ID: 18953379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care physicians in Israel: self-perception of their role in the healthcare system and policy makers' and patients' perception of them as gatekeepers.
    Tabenkin H; Gross R; Greenberg SB; Steinmetz D; Elhayany A
    Isr Med Assoc J; 2001 Dec; 3(12):893-7. PubMed ID: 11794909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Orphanet and the Dutch Steering Committee Orphan Drugs. A European and Dutch databank of information on rare diseases].
    Liem SL
    Ned Tijdschr Tandheelkd; 2008 Nov; 115(11):621-3. PubMed ID: 19058507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A framework to evaluate the effects of small area variations in healthcare infrastructure on diagnostics and patient outcomes of rare diseases based on administrative data.
    Stargardt T; Schreyögg J
    Health Policy; 2012 May; 105(2-3):110-8. PubMed ID: 22342575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Call for a national plan for rare diseases.
    Jaffe A; Zurynski Y; Beville L; Elliott E
    J Paediatr Child Health; 2010 Jan; 46(1-2):2-4. PubMed ID: 19943870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare diseases and orphan drugs.
    Taruscio D; Capozzoli F; Frank C
    Ann Ist Super Sanita; 2011; 47(1):83-93. PubMed ID: 21430345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health research on rare diseases.
    Alonso V; Villaverde-Hueso A; Hens M; Morales-Piga A; Abaitua I; Posada de la Paz M
    Georgian Med News; 2011 Apr; (193):11-6. PubMed ID: 21617266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for rare diseases: mixed assessment in Europe.
    Prescrire Int; 2007 Feb; 16(87):36-42. PubMed ID: 17323539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing drugs for rare genetic diseases: trends and insights.
    Zitter M
    Manag Care; 2005 Feb; 14(2):52-4, 57-60, 63-4; quiz 66-7. PubMed ID: 15782848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research performance of centers of expertise for rare diseases--the influence of network integration, internal resource access and operational experience.
    Hannemann-Weber H; Kessel M; Schultz C
    Health Policy; 2012 May; 105(2-3):138-45. PubMed ID: 22401748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy.
    Liu BC; He L; He G; He Y
    J Public Health Policy; 2010 Dec; 31(4):407-20; discussion 420-1. PubMed ID: 21119648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building treasures for rare disorders.
    Baas M; Huisman S; van Heukelingen J; Koekkoek G; Laan HW; Hennekam RC
    Eur J Med Genet; 2015 Jan; 58(1):11-3. PubMed ID: 25449139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor Group.
    Brecht IB; Graf N; Schweinitz Dv; Frühwald MC; Bielack SS; Schneider DT
    Klin Padiatr; 2009; 221(3):181-5. PubMed ID: 19437371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assuring access to dental care for low-income families in North Carolina. The NC Institute of Medicine Task Force Study.
    Silberman P; Wicker DA; Smith SH; DeFriese GH
    N C Med J; 2000; 61(2):95-8. PubMed ID: 10737031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.